Mavoglurant for alcohol craving in heavy drinkers
Part of Mental health clinical trials.
This trial tests whether a medication called mavoglurant can reduce alcohol cravings and drinking in people who are heavy drinkers with alcohol use disorder and are not looking for treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 50 years old
- You are a heavy drinker (men: 30-70 drinks/week, women: 20-65 drinks/week)
- You have been diagnosed with moderate or severe alcohol use disorder
- You are not currently seeking treatment for alcohol and haven't been in treatment in the last 6 months
- You do not have a current substance use disorder other than tobacco or mild cannabis
- You are generally healthy, especially your liver, and are not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the medication probenecid can help reduce cravings for alcohol and the amount you drink. It is for people who drink heavily and have moderate to severe alcohol use disorder.
This study tests a small implant that slowly releases naltrexone, a medicine that helps reduce alcohol cravings. It may help people with alcohol use disorder stay sober, and the implant offers a long-acting option that doesn't require daily pills.
This study tests a structured training program for young adults who’ve been drinking heavily, to help them reduce drinking or quit. You’ll be asked to complete daily short check-ins and follow study instructions, and you may be randomly assigned to different parts of the program.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
This study tests whether the medication nimodipine (usually used for blood pressure) can help people who drink heavily reduce how much they drink. If you join, you may receive the medication or a placebo (a pill with no active ingredient) and take part in drinking sessions to see how it affects you.
This study tests if a blood-pressure medicine called nimodipine can help people who drink heavily reduce their alcohol intake. The trial involves lab-based drinking sessions and brain scans to understand how the drug works on the brain.
Hear when a new Alcohol Consumption trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.